| scholarly article | Q13442814 |
| review article | Q7318358 |
| P819 | ADS bibcode | 2011PLoSO...625153N |
| P356 | DOI | 10.1371/JOURNAL.PONE.0025153 |
| P932 | PMC publication ID | 3198464 |
| P698 | PubMed publication ID | 22039406 |
| P5875 | ResearchGate publication ID | 51753975 |
| P2093 | author name string | Brittany U Burda | |
| Susan L Norris | |||
| Haley K Holmer | |||
| Lauren A Ogden | |||
| P2860 | cites work | Pharmaceutical industry sponsorship and research outcome and quality: systematic review | Q24673248 |
| Reporting of conflicts of interest in guidelines of preventive and therapeutic interventions | Q24799693 | ||
| Association of funding and conclusions in randomized drug trials: a reflection of treatment effect or adverse events? | Q26701411 | ||
| Evidence-based medicine. A new approach to teaching the practice of medicine | Q28190938 | ||
| Financial ties between DSM-IV panel members and the pharmaceutical industry | Q28236459 | ||
| Uniform format for disclosure of competing interests in ICMJE journals | Q28261652 | ||
| GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables | Q29547885 | ||
| Scope and impact of financial conflicts of interest in biomedical research: a systematic review | Q29616086 | ||
| Evaluating non-randomised intervention studies | Q29619272 | ||
| Clinical guidelines: potential benefits, limitations, and harms of clinical guidelines | Q33534449 | ||
| Translating guidelines into practice. A systematic review of theoretic concepts, practical experience and research evidence in the adoption of clinical practice guidelines. | Q34025120 | ||
| Relationships between authors of clinical practice guidelines and the pharmaceutical industry | Q34520801 | ||
| Task force 1: The ACCF and AHA codes of conduct in human subjects research | Q35920423 | ||
| Influence of industry on renal guideline development | Q36910524 | ||
| Invited Article: Conflicts of interest for authors of American Academy of Neurology clinical practice guidelines | Q37203847 | ||
| Does the type of competing interest statement affect readers' perceptions of the credibility of research? Randomised trial | Q37268456 | ||
| Effects of evidence-based clinical practice guidelines on quality of care: a systematic review | Q37610647 | ||
| The impact of disclosing financial ties in research and clinical care: a systematic review | Q37737486 | ||
| Australian clinical practice guidelines--a national study. | Q37741255 | ||
| Financial interest and its disclosure in scientific publications | Q39471695 | ||
| Does declaration of competing interests affect readers' perceptions? A randomised trial | Q39691480 | ||
| On bias and transparency in the development of influential recommendations | Q43212223 | ||
| Accuracy of conflict-of-interest disclosures reported by physicians. | Q46017044 | ||
| Payments to physicians, medical schools to be illuminated under new reform law. | Q48813775 | ||
| Failure to discount for conflict of interest when evaluating medical literature: a randomised trial of physicians | Q48820172 | ||
| Public disclosure of conflicts of interest: moving the policy debate forward | Q48827269 | ||
| Psychiatrists' relationships with pharmaceutical companies: part of the problem or part of the solution? | Q48855336 | ||
| Does the expert panel at the St Gallen meeting provide an unbiased opinion about the management of women with early breast cancer? | Q49081036 | ||
| A national survey of physician-industry relationships. | Q51017839 | ||
| Conflicts of interest and disclosure in the American Psychiatric Association's Clinical Practice Guidelines. | Q51870047 | ||
| The vexing problem of guidelines and conflict of interest: a potential solution. | Q53075951 | ||
| Developing unbiased diagnostic and treatment guidelines in psychiatry. | Q53105671 | ||
| Attorney General forces Infectious Diseases Society of America to redo Lyme guidelines due to flawed development process. | Q53106282 | ||
| Development of clinical practice guidelines: are we defining the issues too narrowly? | Q53180354 | ||
| Cash interests taint drug advice. | Q53273999 | ||
| Disclosing industry relationships--toward an improved federal research policy. | Q53871687 | ||
| Understanding Financial Conflicts of Interest | Q56172115 | ||
| Physicians' behavior and their interactions with drug companies. A controlled study of physicians who requested additions to a hospital drug formulary | Q72775308 | ||
| Conflict of interest in the debate over calcium-channel antagonists | Q74010214 | ||
| Nonfinancial conflicts of interest in research | Q74735815 | ||
| Effectiveness of clinical practice guideline implementation on lower third molar management in improving clinical decision-making: a randomized controlled trial | Q81303941 | ||
| Scientific evidence underlying the ACC/AHA clinical practice guidelines | Q83396175 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | conflict of interest | Q211067 |
| systematic review | Q1504425 | ||
| P304 | page(s) | e25153 | |
| P577 | publication date | 2011-10-19 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Conflict of interest in clinical practice guideline development: a systematic review | |
| P478 | volume | 6 |
| Q33708348 | A critical appraisal of the quality of adult dual-energy X-ray absorptiometry guidelines in osteoporosis using the AGREE II tool: An EuroAIM initiative |
| Q38650020 | A critical appraisal of the quality of adult musculoskeletal ultrasound guidelines using the AGREE II tool: an EuroAIM initiative. |
| Q55363481 | An evaluation of emergency guidelines issued by the World Health Organization in response to four infectious disease outbreaks. |
| Q38167048 | An explanation of recommendation differences: illustrations from recent atrial fibrillation guidelines |
| Q49993122 | Appraisal of clinical practice guidelines on the management of hypothyroidism in pregnancy using the Appraisal of Guidelines for Research and Evaluation II instrument |
| Q89681208 | Approval processes in evidence-based clinical practice guidelines sponsored by medical specialty societies |
| Q64076356 | Balancing Overuse and Underuse in the Iranian Healthcare System: A Force Field Theory Analysis |
| Q34421838 | Characteristics of physicians receiving large payments from pharmaceutical companies and the accuracy of their disclosures in publications: an observational study |
| Q34362184 | Clinical practice guidelines and consensus statements in oncology--an assessment of their methodological quality. |
| Q24658631 | Conflict of interest disclosure in biomedical research: a review of current practices, biases, and the role of public registries in improving transparency |
| Q36380971 | Conflict of interest disclosures for clinical practice guidelines in the national guideline clearinghouse |
| Q28729747 | Conflict of interest policies for organizations producing a large number of clinical practice guidelines |
| Q38109033 | Conflict of interest reporting in otolaryngology clinical practice guidelines |
| Q28534390 | Conflicts of interest among authors of clinical practice guidelines for glycemic control in type 2 diabetes mellitus |
| Q48232141 | Conflicts of interest and the quality of recommendations in clinical guidelines |
| Q36010776 | Critical Appraisal of the Quality of Clinical Practice Guidelines for Stress Ulcer Prophylaxis |
| Q93270647 | Critical appraisal of papers reporting recommendation on sarcopenia using the AGREE II tool: a EuroAIM initiative |
| Q88013464 | Dental caries prevention in children and adolescents: a systematic quality assessment of clinical practice guidelines |
| Q50146983 | Developing a Clinician Friendly Tool to Identify Useful Clinical Practice Guidelines: G-TRUST. |
| Q36579838 | Disclosures of conflicts of interest in psychiatric review articles |
| Q92914653 | Drivers of the opioid crisis: An appraisal of financial conflicts of interest in clinical practice guideline panels at the peak of opioid prescribing |
| Q40261255 | Electronic Health Records and the Disappearing Patient |
| Q47186805 | Evaluation of Industry Relationships Among Authors of Otolaryngology Clinical Practice Guidelines |
| Q93249821 | Evidence Underlying Recommendations and Payments from Industry to Authors of the National Comprehensive Cancer Network Guidelines |
| Q28682030 | Expanding disease definitions in guidelines and expert panel ties to industry: a cross-sectional study of common conditions in the United States |
| Q36951441 | Financial Relationships between Organizations That Produce Clinical Practice Guidelines and the Biomedical Industry: A Cross-Sectional Study |
| Q96122556 | Financial conflicts of interest among National Comprehensive Cancer Network clinical practice guideline panelists in 2019 |
| Q38261246 | From caveat emptor to caveat venditor: time to stop the influence of money on practice guideline development. |
| Q27318717 | Gathering and learning from relevant clinical data: a new framework |
| Q50319654 | Guideline appraisal with AGREE II: online survey of the potential influence of AGREE II items on overall assessment of guideline quality and recommendation for use. |
| Q44514093 | Guidelines for the Management of Degenerative Cervical Myelopathy and Acute Spinal Cord Injury: Development Process and Methodology |
| Q53280514 | Has "Publish or Perish" Become "Publish and Payment"? Navigating Neurosurgical Research in an Innovative Industry. |
| Q52343836 | Individual and Institutional Corruption in European and US Healthcare: Overview and Link of Various Corruption Typologies. |
| Q58581783 | Innovation and safety in critical care: should we collaborate with the industry? Con |
| Q48412414 | It's NOT FAIR! Or is it? The promise and the tyranny of evidence-based performance assessment |
| Q36119076 | Knowledge transfer: what drug information would specialist doctors need to support their clinical practice? Results of a survey and of three focus groups in Italy |
| Q55514011 | Management of financial conflicts of interests in clinical practice guidelines in Germany: results from the public database GuidelineWatch. |
| Q35220149 | Managing conflicts of interest in the UK National Institute for Health and Care Excellence (NICE) clinical guidelines programme: qualitative study |
| Q53278031 | Meta-research matters: Meta-spin cycles, the blindness of bias, and rebuilding trust. |
| Q57518030 | National stakeholders' perceptions of the processes that inform the development of national clinical practice guidelines for primary healthcare in South Africa |
| Q55615039 | Overdiagnosis or not? 2017 ACC/AHA high blood pressure clinical practice guideline: Consequences of intellectual conflict of interest. |
| Q36192761 | Policies on Conflicts of Interest in Health Care Guideline Development: A Cross-Sectional Analysis |
| Q36263109 | Potential Conflict of Interest and Bias in the RACGP's Smoking Cessation Guidelines: Are GPs Provided with the Best Advice on Smoking Cessation for their Patients? |
| Q38603386 | Primary care clinical practice guidelines in South Africa: qualitative study exploring perspectives of national stakeholders |
| Q38694187 | Quality assessment of osteoporosis clinical practice guidelines for physical activity and safe movement: an AGREE II appraisal. |
| Q34663542 | Quality of clinical practice guidelines for glycemic control in type 2 diabetes mellitus |
| Q92481991 | RE-CODE DCM (REsearch Objectives and Common Data Elements for Degenerative Cervical Myelopathy): A Consensus Process to Improve Research Efficiency in DCM, Through Establishment of a Standardized Dataset for Clinical Research and the Definition of t |
| Q64097491 | Reporting of conflicts of interest and of sponsorship of guidelines in anaesthesiology. A cross-sectional study |
| Q36104646 | Reporting of financial conflicts of interest in clinical practice guidelines: a case study analysis of guidelines from the Canadian Medical Association Infobase |
| Q58103344 | Reporting quality of European and Croatian health practice guidelines according to the RIGHT reporting checklist |
| Q43169747 | Risk awareness and transparency |
| Q38528612 | Setting the research agenda for improving health care in musculoskeletal disorders |
| Q37709366 | Standardized Clinical Assessment And Management Plans (SCAMPs) provide a better alternative to clinical practice guidelines |
| Q90190134 | The Emulation and Adaptation of a Global Model of Clinical Practice Guidelines on Chronic Heart Failure in BRICS Countries: A Comparative Study |
| Q57761111 | The Global Spine Care Initiative: methodology, contributors, and disclosures |
| Q54631008 | The next frontier in critical care guidelines: rapid and trustworthy recommendations. |
| Q45143020 | The quality of clinical practice guidelines in China: a systematic assessment. |
| Q40070335 | Transparency ethics in practice: Revisiting financial conflicts of interest disclosure forms in clinical practice guidelines |
| Q37251703 | Trustworthy patient decision aids: a qualitative analysis addressing the risk of competing interests |
| Q34705062 | Underreporting of conflicts of interest in clinical practice guidelines: cross sectional study |
| Q64247073 | Undisclosed financial ties between guideline writers and pharmaceutical companies: a cross-sectional study across 10 disease categories |
| Q38092146 | Undue industry influences that distort healthcare research, strategy, expenditure and practice: a review |
| Q53196939 | [Guideline development: Going from evidence to recommendations. Challenges and opportunities--a methodologist's view]. |
Search more.